CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-26 | Riggs Josh CEO and President | Option exercise | +47,170 | 50,675 | ||
| 2026-03-26 | Riggs Josh CEO and President | Shares withheld for taxes | −12,310 | $4.11 | $51K | 38,365 |
| 2026-03-26 | Riggs Josh CEO and President | Option exercise · Restricted Stock Units | −47,170 | 141,509 | ||
| 2025-09-28 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +400,000 | 400,000 | ||
| 2025-03-26 | Riggs Josh CEO and President | Grant or award · Restricted Stock Units | +188,679 | 188,679 | ||
| 2024-05-20 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +90,000 | 90,000 | ||
| 2024-04-11 | Riggs Josh CEO and President | Purchase | +3,390 | $2.95 | $10K | 3,505 |
| 2023-08-15 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +40,000 | 40,000 | ||
| 2023-06-09 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +350,000 | 350,000 | ||
| 2023-06-09 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +800,000 | 800,000 | ||
| 2023-02-24 | Riggs Josh CEO | Grant or award · Option to Purchase Common Stock | +116,426 | 116,426 | ||
| 2023-01-17 | Riggs Josh Interim CEO | Grant or award · Option to Purchase Common Stock | +257,485 | 257,485 |
Page 1 of 1 · 12 trades